Contributed analysis
From capacity to capability: Five proofs for India’s pharma future
In Express Pharma, Varun Sharma examines how India can strengthen pharmaceutical development by connecting formulation decisions, evidence, technology transfer, quality and investment.
NEUVIOR summary
Building capability that survives a change of team or site.
The commentary considers how scientific reasoning and practical experience can remain available throughout development and manufacturing, so performance is reproducible beyond the original team.
Make knowledge usable.
Clear development aims, accessible evidence and effective transfer help a receiving organisation understand both the process and the reasons behind it.
Let evidence guide investment.
Quality oversight and investment decisions should respond to demonstrated progress, unresolved questions and learning that can support future programmes.
Primary source context
- Read the Express Pharma article
Publisher hosted guest commentary, published 7 September 2026.